<p>Quantitative data of simulated and experimental metabolite concentrations of all three mouse strains AJ, B6, and PWD for <b>a</b>) control <b>b</b>) DDC treatment, and <b>c</b>) their respective ratios of the metabolites prostaglandin D2, PGD2; 5- and 15-hydroperoxyeicosatetraenoic acid, 5- and 15-HPETE; 15-hydroxyeicosatetraenoic acid, 15-HETE; and arachidonic acid, AA.</p
<p>C3H group and the G6PDx-FB vs. G6PDx group. Seven and 25 differential metabolites were significan...
<p>Pairwise comparisons between rats inoculated with CFA or CFA/SC-H, and control animals. Upward (d...
<p><b>(A)</b> Volcano plot (fold-change vs significance) of the comparison between metabolites of th...
<p>Score plots (A, C) and corresponding loading plots (B, D) for PCA of UPLC/QTOF MS data from mice ...
a<p>Significantly different metabolites between OVX and Fosamax-treated mice or Sham and OVX mice. E...
<p><b>A, C and E.</b> PLS-DA score plots showing distinct metabolomic profiles of PS1 (<b>A</b>), AP...
<p>All the metabolites that have p<0.05 in <i>t</i>-test and VIP score >1 from OPLS-DA are shown for...
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging ...
<p>(A) PCA (R<sup>2</sup>X = 0.642, Q<sup>2</sup> = 0.178) and (B) PLS-DA (R<sup>2</sup>Y = 0.915, Q...
<div><p>Background</p><p>Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease s...
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging...
a<p>Metabolites: (*) represents a material which has not been identified.</p>b<p>Loading: (+) repres...
<p>The differential metabolites in the plasma between G6PDx-FB and G6PDx control mice.</p
<p>A. Concentration of ALT (U/L) in serum of the mice shown as Mean ± SD. B. Concentration of AST (U...
Background: Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging...
<p>C3H group and the G6PDx-FB vs. G6PDx group. Seven and 25 differential metabolites were significan...
<p>Pairwise comparisons between rats inoculated with CFA or CFA/SC-H, and control animals. Upward (d...
<p><b>(A)</b> Volcano plot (fold-change vs significance) of the comparison between metabolites of th...
<p>Score plots (A, C) and corresponding loading plots (B, D) for PCA of UPLC/QTOF MS data from mice ...
a<p>Significantly different metabolites between OVX and Fosamax-treated mice or Sham and OVX mice. E...
<p><b>A, C and E.</b> PLS-DA score plots showing distinct metabolomic profiles of PS1 (<b>A</b>), AP...
<p>All the metabolites that have p<0.05 in <i>t</i>-test and VIP score >1 from OPLS-DA are shown for...
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging ...
<p>(A) PCA (R<sup>2</sup>X = 0.642, Q<sup>2</sup> = 0.178) and (B) PLS-DA (R<sup>2</sup>Y = 0.915, Q...
<div><p>Background</p><p>Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease s...
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging...
a<p>Metabolites: (*) represents a material which has not been identified.</p>b<p>Loading: (+) repres...
<p>The differential metabolites in the plasma between G6PDx-FB and G6PDx control mice.</p
<p>A. Concentration of ALT (U/L) in serum of the mice shown as Mean ± SD. B. Concentration of AST (U...
Background: Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging...
<p>C3H group and the G6PDx-FB vs. G6PDx group. Seven and 25 differential metabolites were significan...
<p>Pairwise comparisons between rats inoculated with CFA or CFA/SC-H, and control animals. Upward (d...
<p><b>(A)</b> Volcano plot (fold-change vs significance) of the comparison between metabolites of th...